Compounds, methods and formulations for the oral delivery of a glucagon like peptide (GLP)-1 compound or an melanocortin 4 receptor (MC4) agonist peptide

Details for Australian Patent Application No. 2004267044 (hide)

Owner Emisphere Technologies, Inc.

Inventors Valluri, Muralikrishna; McGill, John McNeill Iii; Jungheim, Louis Nickolaus; Thrasher, Kenneth Jeff; Herr, Robert Jason

Agent Spruson & Ferguson

Pub. Number AU-B-2004267044

PCT Pub. Number WO2005/019212

Priority 60/496,537 20.08.03 US

Filing date 18 August 2004

Wipo publication date 3 March 2005

Acceptance publication date 3 December 2009

International Classifications

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/24 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/12 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/019212 Priority application(s): WO2005/019212

14 February 2008 Assignment before Grant

  Eli Lilly and Company The application has been assigned to Emisphere Technologies, Inc.

3 December 2009 Application Accepted

  Published as AU-B-2004267044

17 December 2009 Corrigenda

  Applications Accepted - Name Index Under the Name Emisphere Technologies, Inc., Application No. 2004267044, Under INID (72), correct the co-inventor to McGill III, John McNeill

1 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004267046-Chlorine dioxide releasing composite article

2004267038-Systems and methods for producing fluorocarbons